Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 354 of 1,261
  1. US 10968211

    Hepatitis B core protein modulators

    ASSEMBLY BIOSCIENCES, INC. · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  2. US 10968203

    Pyrimidinyl-pyridyloxy-naphthyl compounds and methods of treating IRE1-related diseases and disorders

    The Regents of the University of California · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  3. US 10968180

    Piperidine derivatives as HDAC1/2 inhibitors

    Regenacy Pharmaceuticals, Inc. · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  4. US 10968178

    IP6K inhibitors

    Takeda Pharmaceutical Company Limited · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  5. US 10968166

    4-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

    PTC THERAPEUTICS, INC. · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  6. US 10967346

    Microspheres and method for producing them

    Shenkar Engineering Design Art · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  7. US 10967072

    Short interfering RNA templated lipoprotein particles (siRNA-TLP)

    Northwestern University · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  8. US 10967065

    Compounds for treating biofilm infection

    The Board of Regents of the University of Texas System · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  9. US 10967058

    Foot-and-mouth disease vaccine

    United States of America as represented by the Secretary of the Air Force · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  10. US 10967017

    Traditional Chinese medicine composition and use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  11. US 10967011

    Compositions and methods

    Seres Therapeutics, Inc. · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  12. US 10966977

    Combination of anti-CD20 antibody, P13 kinase-delta selective inhibitor, and BTK inhibitor to treat b-cell proliferative disorders

    TG Therapeutics, Inc. · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  13. US 10967062

    Functionalized nanoparticles and methods of use thereof

    Regents of the University of Minnesota · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  14. US 10966950

    Use of an RXR agonist in treating HER2+ cancers

    The Board of Regents of the University of Texas System · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  15. WO 2021058549

    ANTAGONISTE GRPR RADIOMARQUÉ POUR L'UTILISATION COMME AGENT THÉRAGNOSTIQUE

    ADVANCED ACCELERATOR APPLICATIONS ITALY SRL [IT] · Granted Apr 1, 2021 · Expires Mar 27, 2041

    granted
  16. CA 3156009

    POLYTHERAPIE AVEC DES ANTAGONISTES DU CGRP

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Apr 1, 2021 · Expires Mar 27, 2041

    granted
  17. US 10960079

    Conjugates of an IL-2 moiety and a polymer

    Nektar Therapeutics · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted
  18. US 10961301

    Cell-penetrating anti-DNA antibodies and uses thereof inhibit DNA repair

    The United States Government represented by the Department of Veterans Affairs · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted
  19. US 10960039

    Composition, preparation method and use of the same in manufacture of a product for relieving thyroid nodules

    INFINITUS (CHINA) COMPANY LTD. · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted
  20. US 10960044

    Powder formulation having hypoglycemic and hypolipidemic functions and method for preparing the same

    INFINITUS (CHINA) COMPANY LTD. · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted
  21. US 10959984

    Methods for treating cancer with RORγ inhibitors

    The Regents of the University of California · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted
  22. US 10961205

    1,2,4-oxadiazole derivatives as immunomodulators

    Aurigene Discovery Technologies Limited · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted
  23. US 10961283

    Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted
  24. US 10961282

    Variant adeno-associated viruses and methods of using

    The Regents of the University of California · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.